Harvey M. Lieberman
- Epidemiology top 5%
- Hepatology top 1%
- Infectious Diseases top 10%
- Molecular Biology
- Ecology
- Co-authors
- David A. ShafritzStephanos J. HadziyannisMichael C. KewDouglas R. LaBrecqueStefanos J. HadziyannisJack R. WandsK. J. IsselbacherMorris Sherman
- Topics
- Hepatitis B Virus Studies (9 papers)Hepatitis C virus research (5 papers)Liver Disease Diagnosis and Treatment (5 papers)
- Partner nations
- United StatesGermanyGreece
In The Last Decade
Harvey M. Lieberman
11 papers receiving 806 citations
Peers
Comparison fields: 5 of 55
- Epidemiology 793
- Hepatology 669
- Infectious Diseases 126
- Molecular Biology 77
- Ecology 50
Countries citing papers authored by Harvey M. Lieberman
This map shows the geographic impact of Harvey M. Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey M. Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey M. Lieberman more than expected).
Fields of papers citing papers by Harvey M. Lieberman
This network shows the impact of papers produced by Harvey M. Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey M. Lieberman. The network helps show where Harvey M. Lieberman may publish in the future.
Co-authorship network of co-authors of Harvey M. Lieberman
This figure shows the co-authorship network connecting the top 25 collaborators of Harvey M. Lieberman. A scholar is included among the top collaborators of Harvey M. Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey M. Lieberman. Harvey M. Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 60 | |
| 2 | 52 | |
| 3 | Serum HBV-DNA (hepatitis B virus DNA) in acute and chronic hepatitis B infection. | 2 |
| 4 | 28 | |
| 5 | 67 | |
| 6 | 16 | |
| 7 | 341 | |
| 8 | 181 | |
| 9 | 75 | |
| 10 | 27 | |
| 11 | 10 |
About Harvey M. Lieberman
Harvey M. Lieberman is a scholar working on Hepatology, Epidemiology and Virology, having authored 11 papers that have together received 859 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (669 citations), Epidemiology (793 citations) and Infectious Diseases (126 citations). Harvey M. Lieberman has collaborated with scholars based in United States, Germany and Greece. Frequent co-authors include David A. Shafritz, Stephanos J. Hadziyannis, Michael C. Kew, Douglas R. LaBrecque, Stefanos J. Hadziyannis, Jack R. Wands, K. J. Isselbacher, Morris Sherman, Hans Pópper and David Peterson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.